Get answers to frequently asked questions.
What is BCBS of Illinois' policy on coblation-assisted turbinoplasty and nasal coblation plasma surgery performed under CPT 30802 within SUR 706.001 BCBSIL policy? Why BCBS of Illinois keeps CPT 30802 approval for coblation-assisted turbinoplasty in the "pended" status but proceeds to issue the approval of the procedure to the medical services provider?
Another major healthcare insurance carrier Aetna Insurance considers coblation-assisted turbinoplasty and nasal coblation plasma surgery experimental, investigational and/or unproven because of insufficient evidence in the peer-reviewed literature. Aetna states that the effectiveness of coblation non-thermal volumetric tissue reduction for treatment of hypertrophy of nasal turbinates has not been established, refers to the study by Li PZ et al. (2013) that concludes that the long-term effect of turbinate coblation still needed further observation (see Aetna's CBP 0475 as of 02/14/23 -www.aetna.com/.../0475.html).
Blue Cross and Blue Shield of Illinois, a Division of Health Care Service Corporation,
a Mutual Legal Reserve Company, an Independent Licensee of the Blue Cross and Blue Shield Association
© Copyright 2025 Health Care Service Corporation. All Rights Reserved.
Verint is an operating division of Verint Americas, Inc., an independent company that provides and hosts an online community platform for blogging and access to social media for Blue Cross and Blue Shield of Illinois.
File is in portable document format (PDF). To view this file, you may need to install a PDF reader program. Most PDF readers are a free download. One option is Adobe® Reader® which has a built-in screen reader. Other Adobe accessibility tools and information can be downloaded at https://access.adobe.com.
You are leaving this website/app ("site"). This new site may be offered by a vendor or an independent third party. The site may also contain non-Medicare related information. Some sites may require you to agree to their terms of use and privacy policy.
| | Powered by Verint
